Academic literature on the topic '[89+942]'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '[89+942].'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "[89+942]"

1

Gorina, Valentina, Vadim Korzin, Nikita Saplev, and Ekaterina Melkozerova. "Assessment of genetic resources of representatives of the genus Prunus L. in the conditions of the Crimea." BIO Web of Conferences 25 (2020): 02005. http://dx.doi.org/10.1051/bioconf/20202502005.

Full text
Abstract:
The aim of the work is a comprehensive assessment of the genetic resources of apricot in the Nikitsky Botanical Garden, determination of the main directions of breeding and the selection of appreciable genotypes for further most effective breeding use for creating competitive varieties, and their introduction into production. Based on the conducted studies, it was revealed that the main directions of apricot breeding at the modern level is to determine the possibility of effective targeted selection of parental pairs for creating varieties with high commercial qualities of fruits, high-yieldin
APA, Harvard, Vancouver, ISO, and other styles
2

Quijada, Yanet, and Loreto Villagrán. "Social defeat: Concept and measurement in a Hispanic population." Salud mental 44, no. 1 (2021): 11–16. http://dx.doi.org/10.17711/sm.0185-3325.2021.003.

Full text
Abstract:
Introduction. Social defeat (SD) is defined as a feeling of having lost the fight leading to a loss of valuable status or of important personal goals, and has been associated to depression and suicidal behavior, among other disorders. Furthermore, it has been proposed as a mediating variable between social and clinical elements. Objective. To adapt and validate a Spanish version of the Defeat Scale. Method. A back translation into Spanish was carried out. SD, hopelessness, and social well-being were measured in 546 university students (Mean age = 20.93 years, SD = 2.98; 68.7% females). Results
APA, Harvard, Vancouver, ISO, and other styles
3

Skarin, A. T., M. S. Duh, J. R. Weiner, P. Lefebvre, and M. P. Neary. "Costs associated with intravenous (IV) chemotherapy administration in patients with lung cancer." Journal of Clinical Oncology 25, no. 18_suppl (2007): 18092. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.18092.

Full text
Abstract:
18092 Background: The IV method of chemotherapy administration imposes not only a time burden on patients and facilities, but also has cost implications for payers. This study aims to assess the costs associated with the IV administration of chemotherapies for patients with all forms of lung cancer and for a subset of patients with small cell lung cancer (SCLC) in a large employer-payer claims database. Methods: Using medical claims data from 5.5 million beneficiaries between 01/01/1998 and 01/31/2006, we identified 8,605 patients with lung cancer (ICD-9 codes 162.3–162.9, 176.4, or 197.0) rec
APA, Harvard, Vancouver, ISO, and other styles
4

Walbert, Tobias, and Muhib Alam Khan. "End-of-life care in patients with primary malignant brain tumors: A systematic literature review and analysis." Journal of Clinical Oncology 31, no. 15_suppl (2013): e20703-e20703. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e20703.

Full text
Abstract:
e20703 Background: 80–85% of all adult brain tumors are high-grade glioma (HGG). HGG are typically treated with maximal surgical resection, followed by radiotherapy with concurrent and adjuvant chemotherapy. The median survival for anaplastic glioma is estimated to be 2-5 years and 15 months for patients with glioblastoma. Quality of life (QoL) has become an increasing important outcome assessed in clinical trials as well as in the standard care of brain tumor patients. Despite the inevitable disease trajectory, not much is known about symptoms and needs of brain tumor patients and their caret
APA, Harvard, Vancouver, ISO, and other styles
5

Ko, Jenny J., Brandon David Bernard, Ben Tran, et al. "Conditional survival of patients with metastatic testicular germ-cell tumors (MT-GCT) treated with first-line curative therapy." Journal of Clinical Oncology 34, no. 2_suppl (2016): 472. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.472.

Full text
Abstract:
472 Background: The IGCCCG risk stratification prognosticates survival outcomes in metastatic testicular germ cell tumour (MT-GCT), but how the initial risk changes over time for those who survived since curative treatment (conditional survival) is unknown. We evaluated conditional survival in patients with MT-GCT who were eligible for first-line therapy. Methods: We included patients who were eligible for first-line therapy for MT- GCT at 5 tertiary cancer centres from 1990 to 2012. We assessed 2-year (Y) conditional overall (COS) and disease-free survival (CDFS) at a given timepoint, defined
APA, Harvard, Vancouver, ISO, and other styles
6

Elhasid, Ronit, Gali Avrahami, Aya Abramov, et al. "Characteristics and Outcome of Adolescents with Acute Lymphoblastic Leukemia (ALL) Differ from Young Children in the B-Cell Lineage but Not in the T-Cell Lineage: Experience of the ALL Israeli National Studies (INS)." Blood 112, no. 11 (2008): 902. http://dx.doi.org/10.1182/blood.v112.11.902.902.

Full text
Abstract:
Abstract The outcome of adolescents (≥ 15 years old) with ALL treated on contemporary pediatric ALL protocols has improved and compares favorably with the results of adolescents treated on adult protocols. However, the overall outcome of adolescents is still inferior to that of young children. In order to analyze this difference we compared early response to treatment and biological characteristics of various ALL subtypes (T-cell and non-T-cell), in these age groups. Between January 1989 and June 2008, a total of 942 patients, i.e.,83 (9%) aged ≥ 15 years, 162 (17%) aged 10<15 years and 697
APA, Harvard, Vancouver, ISO, and other styles
7

Kantelhardt, Eva Johanna, Peter Zerche, Pietro Trocchi, et al. "Breast cancer in Sub-Saharan Africa: 1,000 patients with primary breast cancer in Addis Ababa followed for up to 5 years." Journal of Clinical Oncology 30, no. 15_suppl (2012): 580. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.580.

Full text
Abstract:
580 Background: There is little information on breast cancer (BC) patients (pts) receiving standardized treatment in Sub-Saharan Africa. This study evaluates pts presenting 2005-10 at the University Radiotherapy Center in Addis Ababa, the only institution in the country offering standardized radiotherapy, systemic therapy and free endocrine treatment (ET) during that time. Methods: All pts with histologically verified BC were included. Ethical approval was obtained. Axios/AstraZenaca provided free ET. Therefore, the majority of pts underwent regular follow-up (FUP). We analyzed survival at 18
APA, Harvard, Vancouver, ISO, and other styles
8

Sainz, Juan, Carmen Belén Lupiañez, Daniele Campa, et al. "Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium." Blood 124, no. 21 (2014): 2044. http://dx.doi.org/10.1182/blood.v124.21.2044.2044.

Full text
Abstract:
Abstract Type 2-diabetes (T2D) is thought to be a relevant risk factor for multiple myeloma (MM), but the relationship between both traits is still not well understood. Thus, we decided to conduct a population-based case-control study in a population of 1420 MM patients (705 women and 715 men) and 1858 controls (916 women and 942 men) to evaluate whether 58 genome-wide association studies (GWAS)-identified common variants for T2D influence the risk of developing MM. Logistic regression analyses showed that carriers of the KCNQ1rs2237892T allele or CDKN2A-2Brs2383208G/G, IGF-1rs35767T/T and MAD
APA, Harvard, Vancouver, ISO, and other styles
9

Bachier, Carlos R., Paul Shaughnessy, Brad Smith2, Richard Salinas, and Charles F. LeMaistre. "Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor Is an Alternative to Donor Lymphocyte Infusion for Relapse after Allogeneic Stem Cell Transplantation and Is Associated with Increase Immune Effector Cells and Polarization to Type 2 Dendritic Cells." Blood 110, no. 11 (2007): 1647. http://dx.doi.org/10.1182/blood.v110.11.1647.1647.

Full text
Abstract:
Abstract Donor lymphocyte infusion (DLI) is use for relapse after allogeneic stem cell transplant (ASCT). Immune activation with cytokines maybe an alternative to DLI. We administered Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Interleukin-2 (IL-2) at the time of relapse after ASCT in patients (pts) with hematologic malignancies. Pts. received subcutaneous GM-CSF at 500 mcg/day on days 1–14 and IL-2 at 1 × 106 units/m2/day on days 8–14. Pts. were off immunosuppressive therapy and had no prior history of graft versus host disease (GVHD) at the start of treatment. Twelve pts. r
APA, Harvard, Vancouver, ISO, and other styles
10

Singh, D. P., Punam Khare, and P. S. Bisen. "Effect of Ni2+, Hg2+ and Cu2+ on Growth, Oxygen Evolution and Photosynthetic Electron Transport in Cylindrospermum IU 942." Journal of Plant Physiology 134, no. 4 (1989): 406–12. http://dx.doi.org/10.1016/s0176-1617(89)80003-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!